Jorma Tapio Routti
Chairman chez Fibrogen Europe Oy
Profil
Jorma Tapio Routti is currently the Chairman of R.
Ruth Oy and FibroGen Europe Oy.
He previously served as the Executive Chairman of CIM Creative Industries Management Oy, Independent Director of FibroGen, Inc., and Director of Picosun Oy.
Prior to his business career, he was a Professor at Aalto University from 1972 to 1985 and the President of Suomen Itsenäisyyden Juhlarahasto from 1985 to 1995.
He holds a doctorate from the University of California, Berkeley, and graduate and doctorate degrees from Aalto University.
Postes actifs de Jorma Tapio Routti
| Sociétés | Poste | Début |
|---|---|---|
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Chairman | 01/07/2001 |
R. Ruth Oy
 R. Ruth Oy RestaurantsConsumer Services R. Ruth Oy engages in restaurants, real estate and auto businesses. The company was founded in 1883 by Robert Ruthin Kauppapuoti and is headquartered in Jyvaskyla, Finland. | Chairman | 24/12/2010 |
Anciens postes connus de Jorma Tapio Routti
| Sociétés | Poste | Fin |
|---|---|---|
CIM Creative Industries Management Oy
 CIM Creative Industries Management Oy Investment ManagersFinance Creative Industries Management Oy provides investment management services. It offers corporate finance and advisory services to knowledge based and intellectual property rights (IPRs) related industries. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Chairman | 16/01/2006 |
Suomen Itsenäisyyden Juhlarahasto
 Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | President | 01/01/1995 |
| Aalto University | Corporate Officer/Principal | 01/01/1985 |
Picosun Oy
 Picosun Oy Industrial MachineryProducer Manufacturing Picosun Oy engages in the supply of atomic layer deposition thin film coating technology for semiconductor and other industries. Its equipment portfolio includes P-300F, P-300S, P-300B, P-300BV, and P-1000. The company is headquartered Espoo, Finland. | Director/Board Member | - |
| FIBROGEN, INC. | Director/Board Member | - |
Formation de Jorma Tapio Routti
| University of California, Berkeley | Doctorate Degree |
| Aalto University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
CIM Creative Industries Management Oy
CIM Creative Industries Management Oy Investment ManagersFinance Creative Industries Management Oy provides investment management services. It offers corporate finance and advisory services to knowledge based and intellectual property rights (IPRs) related industries. The company was founded in 2000 and is headquartered in Helsinki, Finland. | Finance |
R. Ruth Oy
R. Ruth Oy RestaurantsConsumer Services R. Ruth Oy engages in restaurants, real estate and auto businesses. The company was founded in 1883 by Robert Ruthin Kauppapuoti and is headquartered in Jyvaskyla, Finland. | Consumer Services |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
Suomen Itsenäisyyden Juhlarahasto
Suomen Itsenäisyyden Juhlarahasto Investment ManagersFinance Suomen Itsenäisyyden Juhlarahasto is a Finnish innovation fund directly under the Finnish parliament. It primarily invests in foreign and national funds while making selected follow-up investments in Finnish start-ups and later-stage companies. It can consider investing in foreign companies if it is purposeful for the fund's goals. Its investment focus is in the well-being of the Finnish people, environment, and the economy. The size of its initial venture is up to EUR 2 million and its average investment period per company is from 4 to 10 years. | Finance |
Picosun Oy
Picosun Oy Industrial MachineryProducer Manufacturing Picosun Oy engages in the supply of atomic layer deposition thin film coating technology for semiconductor and other industries. Its equipment portfolio includes P-300F, P-300S, P-300B, P-300BV, and P-1000. The company is headquartered Espoo, Finland. | Producer Manufacturing |
